stockrowBausch + Lomb Corporation
BLCO Healthcare Medical Instruments & Supplies
Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.
- Revenue
- +7.34%
- EPS
- +222.4%
- Free cash flow
- +182.5%
- Total debt
- +2.93%
Quarter to September 2026, against a year earlier
Follow BLCO
Alert me
Bausch + Lomb Corporation (BLCO) Revenue growth
Bausch + Lomb Corporation's revenue growth over the twelve months to 30 September 2026 was 8.88%, up 2.4 percentage points from fiscal 2025 (6.47%). Over the past ten years it has ranged from 0.08% (fiscal 2022) to 15.6% (fiscal 2024); the current reading is higher than 40% of that period. That is in line with the Medical Instruments & Supplies industry median of 8.97% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 6.47% | (9.09) |
| FY2024 | 15.6% | 5.53 |
| FY2023 | 10.0% | 9.95 |
| FY2022 | 0.08% | (10.27) |
| FY2021 | 10.4% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 7.34% | (1.74) |
| Jun 2026 | 9.08% | (0.33) |
| Mar 2026 | 9.41% | (0.36) |
| Dec 2025 | 9.77% | 2.66 |
| 15 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| TFX Teleflex Incorporated compare | 30.7% |
| RGEN Repligen Corporation compare | 13.8% |
| MMSI Merit Medical Systems, Inc. compare | 9.06% |
| ATR AptarGroup, Inc. compare | 8.97% |
| BLCO Bausch + Lomb Corporation | 8.88% |
| COO The Cooper Companies, Inc. compare | 4.73% |
| ALGN Align Technology, Inc. compare | 4.42% |
| AVTR Avantor, Inc. compare | 0.92% |
| MMED MiniMed Group, Inc. compare | — |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on BLCO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement